DUBLIN, March 10, 2022 /PRNewswire/ — The “Artificial Intelligence in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Application; By Therapeutic Area; By Offering; By Technology; By Region; Segment Forecast, 2022 – 2029” report has been added to ResearchAndMarkets.com’s providing.Research and Markets EmblemThe international synthetic intelligence in drug discovery market measurement is anticipated to succeed in USD 5,558.0 million by 2029Artificial Intelligence (AI) makes use of advanced algorithms and machine studying to accumulate important info from enormous datasets. For occasion, AI makes use of RNA sequencing knowledge to acknowledge genes whose expression correlates with a given mobile situation.It employs the latest developments in biology to create cutting-edge medication discovery algorithms. The improve in laptop processing energy, the event of superior algorithms, and the provision of enormous datasets are the primary drivers that led to the developments in machine studying.Based on software, the worldwide synthetic intelligence (AI) in the drug discovery market is clustered into drug optimization & repurposing, preclinical testing, and others. The optimization & repurposing phase accounted for the biggest income share in the trade as it’s economical and calls for solely Electronic Medical Records (EMR) for medication repurposing.Based on therapeutic areas, the worldwide market is assessed into oncology, neurodegenerative illnesses, heart problems, metabolic illnesses, infectious illnesses, and others. The oncology phase accounted for the biggest income share in 2020 because it offers with the analysis and prevention of most cancers.There are some pharmaceutical corporations which might be specializing in integrating synthetic intelligence with medication discovery and growth. For occasion, Pfizer related to IBM Watson Health, an AI platform, to enhance their seek for immuno-oncology remedies. Sanofi partnered with Exscientia to find metabolic-disease therapies.The corporations in the trade are engaged in collaborations and expansions with a number of market platform suppliers to develop medical therapy.Key gamers working in the worldwide market includeStory continuesKey Topics Covered: 1. Introduction1.1. Report Description1.2. Stakeholders2. Executive Summary2.1. Market Highlights3. Research Methodology3.1. Overview3.1.1. Data Mining3.2. Data Sources3.2.1. Primary Sources3.2.2. Secondary Sources4. Global Artificial Intelligence in Drug Discovery Market Insights4.1. Artificial Intelligence in Drug Discovery – Industry Snapshot4.2. Artificial Intelligence in Drug Discovery Market Dynamics4.2.1. Drivers and Opportunities4.2.1.1. Technological developments in AI4.2.1.2. Rising industrial partnerships and collaborations4.2.2. Restraints and Challenges4.2.2.1. Inadequate accessibility of knowledge sets4.2.3. Porter’s Five Forces Analysis4.2.4. PESTLE Analysis4.2.5. Artificial Intelligence in Drug Discovery Industry Trends4.2.6. COVID-19 Impact Analysis5. Global Artificial Intelligence in Drug Discovery Market, by Application5.1. Key Findings5.2. Introduction5.2.1. Global Artificial Intelligence in Drug Discovery Market, by Application, 2017 – 2029 (USD Million)5.3. Drug Optimization & Repurposing5.4. Preclinical Testing6. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area6.1. Key Findings6.2. Introduction6.2.1. Global Artificial Intelligence in Drug Discovery Market, by Therapeutic Area, 2017 – 2029 (USD Million)6.3. Oncology6.4. Neurodegenerative Diseases6.5. Cardiovascular Disease6.6. Metabolic Diseases6.7. Infectious Disease7. Global Artificial Intelligence in Drug Discovery Market, by Offering7.1. Key Findings7.2. Introduction7.2.1. Global Artificial Intelligence in Drug Discovery Market, by Offering, 2017 – 2029 (USD Million)7.3. Software7.4. Services8. Global Artificial Intelligence in Drug Discovery Market, by Technology8.1. Key Findings8.2. Introduction8.2.1. Global Artificial Intelligence in Drug Discovery Market, by Technology, 2017 – 2029 (USD Million)8.3. Machine Learning8.3.1. Global Artificial Intelligence in Drug Discovery Market, By Machine Learning, By Region, 2017 – 2029 (USD Million)8.3.2. Deep Learning8.3.3. Supervised Learning8.3.4. Reinforcement Learning8.3.5. Unsupervised Learning9. Global Artificial Intelligence in Drug Discovery Market, by Geography9.1. Key findings9.2. Introduction9.2.1. Artificial Intelligence in Drug Discovery Market Assessment, By Geography, 2017 – 2029 (USD Million)10. Competitive Landscape10.1. Expansion and Acquisition Analysis10.2. Partnerships/Collaborations/Agreements/Exhibitions11. Company Profiles11.1. Company Overview11.2. Financial Performance11.3. Product Benchmarking11.4. Recent DevelopmentsFor extra details about this report go to https://www.researchandmarkets.com/r/69yh1rMedia Contact:Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outdoors U.S.): +353-1-481-1716CisionView unique content material:https://www.prnewswire.com/news-releases/global-5-55-billion-artificial-intelligence-ai-in-drug-discovery-markets-analysis–forecasts-2017-2021–2022-2027-by-application-therapeutic-area-offering-technology-region-301499963.htmlSOURCE Research and Markets
https://finance.yahoo.com/news/global-5-55-billion-artificial-131500643.html
Global $5.55 Billion Artificial Intelligence (Ai) in Drug Discovery Markets, Analysis & Forecasts, 2017-2021 & 2022-2027 by Application; Therapeutic Area; Offering; Technology; Region
